Related Experiment Video
Updated: Jul 15, 2025

06:53
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
Published on: June 8, 2019
8.7K
Using existing pediatric cancer data from the Gabriella Miller Kids First Data Resource Program
Alexandra Hudson1, Marcia Fournier2, James Coulombe2
1Center for Research Strategy, National Cancer Institute, Bethesda, MD, USA.
JNCI Cancer Spectrum
|October 3, 2023
Summary
The Kids First program offers a valuable data resource for childhood cancer and birth defect research. This initiative aims to uncover genetic causes and improve outcomes for affected children.
Area of Science:
- Genomics
- Pediatric Research
- Bioinformatics
Background:
- Childhood cancer and birth defects are significant causes of mortality in children.
- Existing research suggests a link between birth defects and an increased risk of pediatric cancer.
- The Gabriella Miller Kids First Pediatric Research Program (Kids First) was established to address these critical health issues.
Purpose of the Study:
- To describe the data and support services offered by the Kids First Data Resource Center.
- To introduce the Kids First Data Resource Portal as a public platform for accessing research studies.
- To facilitate the investigation of the genetic etiology of pediatric cancer and birth defects.
Main Methods:
- The Kids First Data Resource Center compiles genetic and clinical data from pediatric cancer and birth defect patients and their families.
- The Kids First Data Resource Portal provides public access to review studies and request data.
- Data integration with CAVATICA, a cloud-based analysis and sharing platform, enhances data accessibility and research capabilities.
Main Results:
- The Kids First Portal hosts data from over 34,000 participants.
- The portal connects researchers with a comprehensive dataset for investigating pediatric diseases.
- The integrated platform supports diverse research inquiries into pediatric cancers and birth defects.
Conclusions:
- The Kids First Portal is a unique, centralized resource for pediatric cancer and birth defect research.
- Uniting genetic and clinical data aids in understanding the underlying causes of these conditions.
- This resource has the potential to significantly improve the lives of children affected by cancer and birth defects.
Related Concept Videos
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Comparing the Survival Analysis of Two or More Groups
218
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
218
Kaplan-Meier Approach
178
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178

